Skip to main content

Home/ Vitamin D/ Group items tagged epidemiological April women Hollis cebp

Rss Feed Group items tagged

Matti Narkia

Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Col... - 0 views

    Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

    Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG.
    Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):889-94. Epub 2008 Apr 1.
    PMID: 18381472
    doi: 10.1158/1055-9965.EPI-07-2594

    In this prospective study of postmenopausal women, we did not observe an inverse association between circulating 25(OH)D or 1,25(OH)2D and breast cancer risk, although we cannot exclude an association in younger women or with long-term or earlier exposure
Matti Narkia

Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Can... - 0 views

    Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
    Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.
    PMID: 17416771
    doi: 10.1158/1055-9965.EPI-06-0981

    Overall, our results do not suggest that plasma vitamin D levels are associated with risk of ovarian cancer. However, we observed significant associations in some subgroups, which should be evaluated further in other studies because increasing vitamin D intake is an easy preventive measure to adopt.
1 - 2 of 2
Showing 20 items per page